No evidence of chromosome damage in children and adolescents with differentiated thyroid carcinoma after receiving 131I radiometabolic therapy, as evaluated by micronucleus assay and microarray analysis

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 11, 2008, Pages 2113-2121

  Federico, Giovanni ^a   Boni, Giuseppe ^a   Fabiani, Barbara ^b   Fiore, Lisa ^a   Lazzeri, Patrizia ^a   Massart, Francesco ^a   Traino, Claudio ^a   Verola, Carmela ^b   Saggese, Giuseppe ^a   Mariani, Giuliano ^a   Scarpato, Roberto ^b  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

131I treatment; Chromosome damage; Differentiated thyroid carcinoma; Micronuclei; Peripheral lymphocytes

Indexed keywords

DOUBLE STRANDED DNA; IODINE 131;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CELL COUNT; CELL DAMAGE; CHROMOSOME DAMAGE; CLINICAL ARTICLE; DNA REPAIR; DNA STRAND BREAKAGE; FEMALE; GENE EXPRESSION; GENE MUTATION; GENOME; HUMAN; HUMAN CELL; MALE; MICROARRAY ANALYSIS; MICRONUCLEUS TEST; NUCLEOTIDE SEQUENCE; PERIPHERAL LYMPHOCYTE; SCHOOL CHILD; SIDE EFFECT; T LYMPHOCYTE; THYROID CARCINOMA; TUMOR DIFFERENTIATION;

ADOLESCENT; APOPTOSIS; CELL NUCLEUS; CHILD; CHROMOSOMES; DNA DAMAGE; DNA REPAIR; FEMALE; GENE EXPRESSION PROFILING; GENOME; HALF-LIFE; HUMANS; IODINE RADIOISOTOPES; MALE; MICRONUCLEUS TESTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; T-LYMPHOCYTES; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 53649086789     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-0867-1     Document Type: Article

References (53)

1. B Jarzab D Handkiewicz-Junak J Wloch A Kukulska A Prokurat Z Wygoda 2005 Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review Endocr-Relat Cancer 12 773 803
2. GK Livingston AE Foster HR Elson 1993 Effect of in vivo exposure to iodine-131 on the frequency and persistence of micronuclei in human lymphocytes J Toxicol Environ Health 40 367 75
3. 1311 Cancer Lett 91 199 204
4. S Gutiérrez E Carbonell P Galofré A Creus R Marcos 1999 Cytogenetic damage after 131-iodine treatment for hyperthyroidism and thyroid cancer. A study using the micronucleus test Eur J Nucl Med 26 1589 96
5. V Lambert H Thierens M Monsieurs C Roncancio C Laurent 2001 Translocation frequencies measured in patients one year after radioactive iodine therapy for thyrotoxicosis Int J Radiat Biol 77 679 85
6. 131I therapy of thyroid cancer: assessment by micronucleus assay of B lymphocytes J Nuclear Med 45 608 11
7. A Hernández N Xamena S Gutiérrez A Velázquez A Creus J Surrallés 2006 Basal and induced micronucleus frequencies in human lymphocytes with different GST and NAT2 genetic backgrounds Mutat Res 606 12 20
8. D Konukoǧlu HH Hatemi S Arikan M Demir T Akçay 1998 Radioiodine treatment and oxidative stress in thyroidectomised patients for differentiated thyroid cancers Pharmacol Res 38 311 5
9. O Monteiro Gil NG Oliveira AS Rodrigues A Laires TC Ferriera E Lambert 2000 No evidence of increased chromosomal aberrations and micronuclei in lymphocytes from nonfamilial thyroid cancer patients prior to radiotherapy Cancer Genet Cytogenet 123 55 60
10. M Ballardin F Gemignani L Bodei G Mariani M Ferdeghini AM Rossi 2002 Formation of micronuclei and of clastogenic factor(s) in patients receiving therapeutic doses of iodine-131 Mutat Res 514 77 85
11. M Ballardin R Barsacchi L Bodei N Caraccio R Cristofani F Di Martino 2004 Oxidative and genotoxic damage after radio-iodine therapy of Graves' hyperthyroidism Int J Radiat Biol 80 209 16
12. S Bonassi A Znaor H Norppa L Hagmar 2004 Chromosomal aberrations and risk of cancer in humans: an epidemiologic perspective Cytogenet Genome Res 104 376 82
13. L Hagmar U Stromberg S Bonassi IL Hansteen LE Knudsen C Lindholm 2004 Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts Cancer Res 64 2258 63
14. MP Longhese D Mantiero M Clerici 2006 The cellular response to chromosome breakage Mol Microbiol 60 1099 108
15. A Patel S Jhiang S Dogra R Terrell PA Powers C Fenton 2002 Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents Pediat Res 52 737 44
16. JW Haveman KM van Tol CW Rouwe DA Piers JT Plukker 2003 Surgical experience in children with differentiated thyroid carcinoma Ann Surg Oncol 10 15 20
17. E Berthe M Henry-Amar J-J Michels J-P Rame P Berthet E Babin 2004 Risk of second primary cancer following differentiated thyroid cancer Eur J Nucl Med Mol Imaging 31 685 91
18. RJ Weigel IR McDougall 2006 The role of radioactive iodine in the treatment of well-differentiated thyroid cancer Surg Oncol Clin N Am 15 625 38
19. EM Kaptein H Levenson ME Siegel M Gadallah M Akmal 2000 Radioiodine dosimetry in patients with end-stage renal disease receiving continuous ambulatory peritoneal dialysis therapy J Clin Endocrinol Metab 85 3058 64
20. M Lassmann M Luster H Hänscheid C Reiners 2005 Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer (Letters to the Editor) J Nucl Med 46 899
21. Sobin LH, Wittekind CH. TNM classification of malignant tumors. 6th ed. New York: Wiley-Liss; 2002.
22. R Scarpato L Migliore G Angotzi A Fedi L Miligi N Loprieno 1996 Cytogenetic monitoring of a group of Italian floriculturists: no evidence of DNA damage related to pesticide exposure Mutat Res 367 73 82
23. M Fenech 2005 In vitro micronucleus technique to predict chemosensitivity Methods Mol Med 111 3 32
24. M Neri M Ceppi LE Knudsen DF Merlo R Barale R Puntoni 2005 Baseline micronuclei frequency in children: estimates from meta- and pooled analyses Environ Health Perspect 113 1226 9
25. 131I therapy Radiat Environ Biophys 43 7 13
26. N Holland P Harmatz D Golden A Hubbard Y-Y Wu J Bae 2007 Cytogenetic damage in blood lymphocytes and exfoliated epithelial cells of children with inflammatory bowel disease Pediat Res 61 209 14
27. T Erselcan S Sungu S Ozdemir B Turgut D Dogan O Ozdemir 2004 Iodine-131 treatment and chromosomal damage: in vivo dose-effect relationship Eur J Nucl Med Mol Imaging 31 676 84
28. N Watanabe K Yokoyama S Kinuya N Shuke M Shimizu R Futatsuya 1998 Radiotoxicity after iodine-131 therapy for thyroid cancer using the micronucleus assay J Nucl Med 39 436 40
29. C Catena D Conti G Trenta E Righi F Breuer FF Melacrinis 2000 Micronucleus yield and colorimetric test as indicators of damage in patients' lymphocytes after 131-I therapy J Nucl Med 41 1522 4
30. S Puerto R Marcos MJ Ramírez P Galofré A Creus J Surrallés 2000 Equal induction and persistence of chromosome aberrations involving chromosomes 1, 4 and 10 in thyroid cancer patients treated with radioactive iodine Mutat Res 469 147 58
31. I Emerit M Quastel J Goldsmith L Merkin A Levy L Cernjavski 1997 Clastogenic factors in the plasma of children exposed at Chernobyl Mutat Res 373 47 54
32. K Bishay K Ory J Lebeau C Levalois M-F Olivier S Chevillard 2000 DNA damage-related gene expression as biomarkers to assess cellular response after gamma irradiation of a human lymphoblastoid cell line Oncogene 19 916 23
33. VG Tusher R Tibshirani G Chu 2001 Significance analysis of microarrays applied to the ionizing radiation response PNAS 98 5116 21
34. SM Lee B Youn CS Kim CS Kim C Kang J Kim 2005 Gamma-irradiation and doxorubicin treatment of normal human cells cause cell cycle arrest via different pathways Mol Cells 20 331 8
35. K Daino S Ichimura M Nenoi 2006 Both the basal transcriptional activity of the GADD45A gene and its enhancement after ionizing irradiation are mediated by AP-1 element Biochimica Biophysica Acta 1759 458 69
36. E Kis T Szatmári M Keszei R Farkas O Ésik K Lumniczky 2006 Microarray analysis of radiation response genes in primary human fibroblasts Int J Radiat Oncol Biol Phys 66 1506 14
37. M Mori MA Benotmane I Tirone EL Hooghe-Peters C Desaintes 2005 Transcriptional response to ionizing radiation in lymphocyte subsets Cell Mol Life Sci 62 1489 501
38. ET Sakamoto-Hojo SS Mello E Pereira AL Fachin RS Cardoso CM Junta 2003 Gene expression profiles in human cells submitted to genotoxic stress Mutat Res 544 403 13
39. MA Chaudhry 2006 Bystander effect: biological endpoints and microarray analysis Mutat Res 597 98 112
40. K Bishay K Ory M-F Olivier J Lebeau C Levalois S Chevillard 2001 DNA damage-related RNA expression to assess individual sensitivity to ionizing radiation Carcinogenesis 22 1179 83
41. FW Chen YA Ioannou 1999 Ribosomal proteins in cell proliferation and apoptosis Int Rev Immunol 18 429 48
42. 2 phases of cell cycle Cancer Lett 195 221 33
43. S Jin L Mazzacurati X Zhu T Tong Y Song S Shujuan 2003 Gadd45a contributes to p53 stabilization in response to DNA damage Oncogene 22 8536 40
44. A Cataldi S Miscia L Centurione M Rapino D Bosco G Grifone 2002 Role of nuclear PKC delta in mediating caspase-3-upregulation in Jurkat T leukemic cells exposed to ionizing radiation J Cell Biochem 86 553 60
45. RA Roberts C Michel B Coyle C Freathy K Cain E Boitier 2004 Regulation of apoptosis by peroxisome proliferators Toxicol Lett 149 37 41
46. C-L Mok G Gil-Gómez O Williams M Coles S Taga M Tolaini T Norton D Kioussis HJM Brady 1999 Bad can act as a key regulator of T cell apoptosis and T cell development J Exp Med 189 575 86
47. AM Ranger J Zha H Harada SR Datta NN Danial AP Gilmore 2003 Bad-deficient mice develop diffuse large B cell lymphoma PNAS 100 9324 29
48. SY Seo Y Chen I Ivanovska AM Ranger SJ Hong VL Dawson 2004 BAD is a pro-survival factor prior to activation of its pro-apoptotic function J Biol Chem 279 42240 49
49. NJ Yoo JW Lee EG Jeong YH Soung SW Nam JY Lee 2006 Expressional analysis of anti-apoptotic phospho-BAD protein and mutational analysis of pro-apoptotic BAD gene in hepatocellular carcinomas Dig Liv Dis 38 683 7
50. A Dardano M Ballardin M Ferdeghini E Lazzeri C Traino N Caraccio 2007 Anticlastogenic effect of ginkgo biloba extract in graves' disease patients receiving radioiodine therapy J Clin Endocrinol Metab 92 4286 9
51. D Handkiewicz-Junak J Wloch J Roskosz J Krajewska A Kropinska L Pomorski 2007 Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer J Nucl Med 48 879 88
52. AP Brown J Chen YJ Hitchcock A Szabo DC Shrieve JD Tward 2008 The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer J Clin Endocrinol Metab 93 504 15
53. A Vaiano C Traino G Boni M Grosso P Lazzeri Colato 2007 Comparison between remnant and red-marrow absorbed dose in thyroid cancer patients submitted to 131I ablative therapy after rh-TSH stimulation versus hypothyroidism induced by l-thyroxine withdrawal Nucl Med Commun 28 215 23